Pediatrie Slunicko s.r.o.
- Address
- lock Available on a paid plan
Bacterial Infections and Mycoses
At Pediatrie Slunicko s.r.o. a private practice in Prague, researchers focus on preventing serious bacterial infections in young children. Current studies evaluate new pneumococcal and meningococcal vaccines to protect infants, toddlers and pre‑term babies. The trials aim to show that the immune response generated by the investigational products is at least as strong as, or stronger than, that of existing vaccines, while monitoring safety in the pediatric population.
- Assessment of IgG antibody response to a 21‑valent pneumococcal conjugate vaccine
- Comparison of serotype‑specific immunity between investigational and licensed pneumococcal vaccines
- Evaluation of safety and immunogenicity of a pentavalent meningococcal ABCYW vaccine across age groups
- Measurement of functional antibody activity against meningococcal serogroups A, C, W‑135, Y and B
The site has conducted two pediatric vaccine trials under the guidance of two investigators, contributing valuable data to the European effort against bacterial infections.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 1 therapeutic areas and 15 of 58 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 58 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Sanofi Pasteur Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Pediatrie Slunicko s.r.o.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Immunogenicity and Safety of Pentavalent Meningococcal ABCYW Vaccine in Pediatric Populations Compared to Licensed Meningococcal Vaccines | Sanofi Pasteur Inc. | Phase II | Not Recruiting | Mar 2025 | — |
IMP list
lock Showing 1 of 58 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE) | 1 | Unknown | 2025-03-10 | 2025-03-10 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.